Mobile Contingency Management for Concurrent Abstinence From Alcohol and Smoking

PHASE4CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

March 2, 2020

Study Completion Date

March 2, 2020

Conditions
Smoking CessationAlcohol Drinking
Interventions
OTHER

Nicotine Replacement Therapy

Participants will be prescribed NRT patch and one nicotine rescue method (e.g., nicotine gum, lozenge, inhaler) for use during the post-quit phase of the study. Participants will be given the choice between nicotine gum or nicotine lozenge, and will be instructed to use the rescue method as needed to reduce cigarette cravings

DRUG

Bupropion

All participants who are medically eligible will be prescribed bupropion, which they will start two weeks prior to their quit day. Dosage will be 150 mg/daily for days 1-7 and 300 mg/daily (administered in two daily doses) until the 6-month follow-up.

BEHAVIORAL

Cognitive Behavioral Treatment

Participants will receive 4 60-minute sessions of CBT telephone counseling for alcohol and smoking cessation.

BEHAVIORAL

Mobile Contingency Management

Participants will be asked to provide video recordings of themselves taking carbon monoxide readings in order to confirm smoking abstinence, and breathalyzer to confirm abstinence from alcohol. Participants are asked to upload these videos to the study's secured server, and are provided monetary reward for videos that suggest smoking abstinence and alcohol abstinence.

BEHAVIORAL

Mobile Monitoring

Participants will be asked to provide video recordings of themselves taking carbon monoxide readings and breathalyzer. Participants are asked to upload these videos to the study's secured server, and are provided monetary reward for providing the video recordings, regardless of abstinence.

Trial Locations (1)

27706

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Duke University

OTHER